Limiting the Costs – the Multifarious Effects of Falsified and Substandard Medicines

By PerkinElmer

There are ongoing global efforts to combat the dissemination of falsified and substandard medicines, which can pose a significant threat to public health and the product brand.

Falsified medicines are those that have been deliberately and fraudulently tampered with and should be distinguished from substandard medicines, which are made legitimately but fail to meet either their quality standards or specifications, or both.

To read more, please download this free white paper.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.